2014-03-17T12:39:29-05:00 2013-06-30 911194016 CLARK NUBER PS 10900 NE 4TH STREET SUITE 1700 BELLEVUE WA 98004 990 2012-07-01 911935159 SEATTLE CANCER CARE ALLIANCE SEAT 2062881000 825 EASTLAKE AVENUE EAST PO BOX 19023 SEATTLE WA 981091023 JONATHAN TINGSTAD 2062881000 2014-03-17 1 SARA ELIZABETH J HYRE P00235495 4254544919 2012 2015-11-30 17:44:51Z FRED APPELBAUM MD 1100 FAIRVIEW AVE N SEATTLE WA 98109 584827321 0 X WWW.SEATTLECCA.ORG X 1998 WA SEATTLE CANCER CARE ALLIANCE (SCCA) IS A NATIONAL CANCER INSTITUTE (NCI)(SEE SCHEDULE O) DESIGNATED COMPREHENSIVE CANCER TREATMENT CENTER THAT UNITES THE DOCTORS FROM FRED HUTCHINSON CANCER RESEARCH CENTER, UW MEDICINE, AND SEATTLE CHILDREN'S. OUR GOAL, EVERY DAY, IS TO TURN CANCER PATIENTS INTO CANCER SURVIVORS. OUR PURPOSE IS TO LEAD THE WORLD IN THE PREVENTION AND TREATMENT OF CANCER. 18 17 1330 340 0 0 2564192 3643872 348949857 384863259 6617931 4125031 -47698 32170 358084282 392664332 935916 1632418 0 0 88365958 94579014 0 43030 46918 238605331 269361205 327907205 365615667 30177077 27048665 415596706 440984867 153584769 157922861 262011937 283062006 X SEATTLE CANCER CARE ALLIANCE UNITES THE DOCTORS FROM FRED HUTCHINSON CANCER RESEARCH CENTER (FHCRC), UW MEDICINE, AND SEATTLE CHILDREN'S. OUR GOAL IS TO TURN CANCER PATIENTS INTO CANCER SURVIVORS. OUR PURPOSE IS TO LEAD THE WORLD IN THE PREVENTION AND TREATMENT OF CANCER. WITH OUR AFFILIATE ORGANIZATIONS, SCCA IS HOME TO THE WORLD'S BEST SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, PATHOLOGISTS, AND RADIOLOGISTS. PATIENTS RECEIVE THE LATEST TAILORED COURSE OF TREATMENTS AND THERAPIES FOR CANCER AND HAVE ACCESS TO NEW DRUGS AND TREATMENTS THAT ARE UNDER INVESTIGATION IN CLINICAL STUDIES AVAILABLE AT SCCA AND LIMITED SITES AROUND THE COUNTRY. FHCRC, WITH ITS PARTNERS UW MEDICINE, SEATTLE CHILDREN'S, AND SCCA COMPRISE THE FRED HUTCHINSON/UW CANCER CONSORTIUM. THE CONSORTIUM IS ONE OF 40 COMPREHENSIVE CANCER CENTERS DESIGNATED BY THE NATIONAL CANCER INSTITUTE (NCI) AND HAS RECEIVED MORE FUNDING FOR CANCER RESEARCH THAN ANY OTHER NCI SITE IN THE COUNTRY. 1 0 278295623 1517030 391888822 SCCA'S FOCUS IS TO SPEED UP THE TRANSFER OF NEW DIAGNOSTIC AND TREATMENT TECHNIQUES FROM THE RESEARCH SETTING TO PATIENT CARE. THE HIGHLY INTEGRATED APPROACH TO CANCER RESEARCH AND TREATMENT AMONG SCCA PARTNER ORGANIZATIONS SUPPORTS THE FLOW OF SCIENTIFIC INFORMATION AMONG RESEARCHERS, CLINICIANS, AND PATIENTS, THEREBY ACCELERATING THE DEVELOPMENT OF NEW KNOWLEDGE AND TREATMENT OF VARIOUS CANCERS. DURING THE YEAR ENDED JUNE 30, 2013, SCCA TREATED 6,625 NEW PATIENTS WITHIN THE CANCER AND BONE MARROW/STEM CELL TRANSPLANT PROGRAMS. SCCA ALSO HAD 82,598 CLINIC VISITS, 96,386 INFUSION HOURS, 13,984 RADIATION ONCOLOGY TREATMENTS, AND PERFORMED 46,522 IMAGING SCANS.AS PART OF SCCA'S COMMITMENT TO ADVANCING THE STANDARD OF CANCER CARE, IT OFFERS MANY EDUCATIONAL OPPORTUNITIES FOR HEALTH CARE PROFESSIONALS OF ALL KINDS SEEKING THE SPECIALIZED KNOWLEDGE IN ONCOLOGY SETTINGS TO EARN CONTINUING EDUCATION CREDITS. SCCA IS DESIGNATED AS AN INSTRUCTIONAL SITE FOR BACHELOR AND ADVANCED DEGREE CANDIDATES FROM SEVERAL INSTITUTIONS AROUND THE PUGET SOUND AREA. IN ADDITION, SCCA HAS MANY EDUCATIONAL OFFERINGS TO CANCER PATIENTS, CAREGIVERS, THEIR FAMILIES, AND CANCER SURVIVORS. 2878577 115389 1780006 SEATTLE CANCER CARE ALLIANCE HOUSE IS A TEMPORARY MEDICAL HOUSING FACILITY. IT IS AN 80-ROOM FACILITY THAT PROVIDES AN AFFORDABLE HOME FOR CANCER PATIENTS AND THEIR FAMILIES WHO COME TO SEATTLE FOR EXTENDED TREATMENT WITH SCCA. THE SIX-STORY "BUILT GREEN" BUILDING WAS DESIGNED TO ADDRESS PATIENTS' PHYSICAL, EMOTIONAL, AND LOGISTICAL CHALLENGES. SCCA HOUSE IS LOCATED VERY CLOSE TO THE SCCA OUTPATIENT CLINIC AND OFFERS SHUTTLE SERVICE TO THE SCCA CLINIC. THE SCCA HOUSE OFFERS PATIENTS A HOME AWAY FROM HOME WITH WELLNESS AND EXERCISE ROOMS, IN ROOM KITCHENETTES, A LARGE COMMON KITCHEN AND DINING ROOM, RESOURCE CENTER AND LIBRARY, THEATER, EXERCISE ROOM, IN-ROOM, SEPARATE CAREGIVER SLEEPING AREAS, FREE LAUNDRY 24 HRS/DAY, FREE WIRELESS INTERNET ACCESS, SECURE BUILDING, GARAGE AND PARKING, INFECTION CONTROL MEASURES, AS WELL AS A ROOFTOP GARDEN. THE COMMON AREAS SERVE AS MEETING CENTERS FOR OUR COMMUNITY PARTNERS. SCCA HOUSE IS AN EXAMPLE OF SCCA'S COMMITMENT TO THE MISSION OF PROVIDING FAMILY CENTERED PATIENT CARE. -8708056 SCCA PROTON THERAPY, A PROCURE CENTER (CENTER) LOCATED ON UW MEDICINE'S NORTHWEST HOSPITAL & MEDICAL CENTER CAMPUS, OPENED DURING 2013. AN ADVANCED FORM OF RADIATION TREATMENT, PROTON THERAPY CAN BE CALIBRATED WITH GREAT PRECISION TO SELECTIVELY KILL CANCER CELLS. THE CLINICAL BENEFITS PROTON THERAPY OFFERS OVER STANDARD X-RAY TREATMENT FOR CERTAIN TYPES OF CANCER ARE BECOMING INCREASINGLY WELL KNOWN. THE ACCURACY OF THE DELIVERY OF PROTON RADIATION, FOR EXAMPLE, REDUCES DAMAGE TO THE HEALTHY TISSUES AND ORGANS SURROUNDING TUMORS. OTHER BENEFITS INCLUDE FEWER SIDE EFFECTS, INCLUDING A DECREASED RISK OF DEVELOPING SECONDARY TUMORS (CANCERS THAT RESULT FROM RADIATION TREATMENT). SINCE PROTON THERAPY WAS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION TO TREAT PATIENTS IN 1988, THE MEDICAL COMMUNITY HAS CONTINUED TO CONDUCT RESEARCH ON THE USE OF PROTONS IN TREATING DIFFERENT TYPES OF CANCER THROUGH CLINICAL TRIALS. OVER THE YEARS, MANY PATIENTS HAVE VOLUNTEERED TO TAKE PART IN THESE CLINICAL TRIALS TO HELP FIND IMPROVEMENTS IN FIGHTING CANCER WITH PROTON THERAPY. THE CENTER, WITH OUR PARTNER THE UNIVERSITY OF WASHINGTON, IS CURRENTLY PARTICIPATING IN MANY CLINICAL TRIALS. IN OUR QUEST TO LOOK FOR WAYS TO IMPROVE THE LIVES OF PATIENTS WITH CANCER, OUR CENTER WILL PARTICIPATE IN CLINICAL TRIALS TO FURTHER OUR KNOWLEDGE OF THE BENEFITS OF PROTON THERAPY IN MANY TUMOR TYPES. OUR DOCTORS VIEW THE NEW CENTER AS A TREMENDOUS OPPORTUNITY TO TAKE THE LEAD IN ACTIVE CLINICAL INVESTIGATIONS THAT WILL HELP DEFINE THE ROLE OF PROTON THERAPY IN FUTURE CANCER TREATMENT. ONGOING STUDIES CONDUCTED BY SCCA DOCTORS WILL HELP CHART A CLEAR COURSE FOR THE USE OF PROTON RADIATION IN ACHIEVING THE BEST POSSIBLE OUTCOMES IN TREATING CANCER. 281174200 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 1 0 0 1 1 0 1 1 1 1 1 1 0 0 0 0 0 0 1 0 0 1 1 1 0 0 0 0 0 0 1 1 120 0 1 1330 1 0 0 0 0 0 0 0 0 0 0 X 18 17 1 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 1 AL AK AZ AR CO CT FL HI IL KS KY ME MD MA MI MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI MN X JONATHAN TINGSTAD 2062881058 825 EASTLAKE AVENUE EAST PO BOX SEATTLE WA 98109 ROBB BAKEMEIER 8.50 X X 0 0 0 CARL BEHNKE 5.00 X X 0 0 0 KIMBERLY MCNALLY MN RN 2.00 X X 0 0 0 BOB GERTH 5.00 X X 0 0 0 MARK GROUDINE MD PHD 2.00 X 0 0 0 LISA BRANDENBURG 2.00 X 0 0 0 MIKE DELMAN 2.00 X 0 0 0 JONELLE JOHNSON 5.50 X 0 0 0 RICH JONES 3.00 X 0 0 0 ROB MACAULAY 2.50 X 0 0 0 RUTH MAHAN 3.00 X 0 0 0 LINDA MATTOX 1.00 X 0 0 0 RICH MCCUNE 2.50 X 0 0 0 SHAN MULLIN 4.00 X 0 0 0 BROOKS RAGEN 1.50 X 0 0 0 JOHNESE SPISSO 5.00 X 0 0 0 BRUDER STAPLETON MD 1.50 X 0 0 0 MYRA TANITA 2.00 X 0 0 0 FRED APPELBAUM MD 14.00 X 446442 0 0 NORMAN HUBBARD 55.00 X 550514 0 47334 MADELINE BUELT 55.00 X 342412 0 51929 F MARC STEWART MD 28.00 X 367348 0 0 JONATHAN TINGSTAD 55.00 X 399261 0 52154 DEBORAH GENTZEN 55.00 X 357484 0 51436 DAVID ACKERSON 55.00 X 328723 0 42148 CHERYL WYMAN 55.00 X 206690 0 35252 GRETCHEN HANNA 55.00 X 209183 0 35135 JOSEPH NORTON 55.00 X 202485 0 37923 ZAKARIA RAMADAN-JRADI 55.00 X 196818 0 37359 ALEANA WAITE 55.00 X 188218 0 32271 KRISTINE LOGAN 55.00 X 168475 0 23140 LINDA LAKE 55.00 X 167552 0 23312 SUSAN HAMMOND 55.00 X 172646 0 30254 MOREEN DUDLEY 55.00 X 153854 0 26265 CAMILLE RAPACZ 55.00 X 151677 0 27639 ALPHONSO EMERY 55.00 X 163766 0 21749 MARGARET OWENS 55.00 X 165626 0 15892 BARBARA JAGELS 55.00 X 144516 0 31068 MICHELLE HALL 55.00 X 142581 0 26367 SHARI MCCLURE 55.00 X 140989 0 19725 CLAIRE BECK KEELER 55.00 X 137470 0 29813 5504730 0 698165 107 0 1 1 UNIVERITY OF WASHINGTON 1959 NE 59TH AVE SUITE 1005 SEATTLE WA 98104 HEALTHCARE, SERVICES, SUPPLIES 162107298 FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVE N SEATTLE WA 98109 ADMIN, SUPPORT, SVCS CONSULT. 19773377 SEATTLE CHILDRENS HOSPITAL PO BOX 50020 SEATTLE WA 98145 HEALTHCARE SERVICES 14832944 NATIONAL MARROW DONOR PROGRAM 3001 BROADWAY ST NE MINNEAPOLIS MN 55413 MARROW TRANSPLANT SERVICES 9279161 PUGET SOUND BLOOD CENTER 921 TERRY AVENUE SEATTLE WA 98104 BLOOD & TISSUE SERVICES 5230073 82 269762 19484 954537 2400089 299846 3643872 CANCER HOSP/OUTPATIENT 622310 300568105 300116539 451566 MEDICARE/MEDICAID PMTS 923130 89897633 89897633 PATIENT HOUSING 624221 1780006 1780006 INTERAFFILIATE AGMTS 900099 1325571 558904 766667 SCCA PROTON THERAPY 900099 -8708056 -8708056 384863259 5202433 5202433 2 2 190656100 4790 191637848 100446 -981748 -95656 -1077404 -1077404 1804 19484 1804 0 357548 422891 -65343 -65343 EDUCATIONAL EVENTS 923110 96485 96485 SETTLEMENT INCOME 900099 1028 1028 97513 392664332 392450595 0 -3430135 X 971183 971183 661235 661235 5189089 2085948 3103141 69272505 44382412 24890093 4169095 2726288 1442807 10079484 6307287 3772197 5868841 3561308 2307533 49252064 25343992 23908072 1355377 1355377 264574 264574 203345 203345 43030 43030 556517 556517 72629490 70400822 2228668 3160089 3128791 31298 96213305 93149079 3060338 3888 3982343 806120 3176223 204630 204630 5833896 1120251 4713645 441250 88124 353126 750916 63618 687298 6429938 6429938 15729495 8577627 7151868 821231 410256 410975 BUSINESS TAXES 9112678 8964676 148002 BAD DEBT 1756724 1756724 DUES & SUBSCRIPTIONS 343716 10765 332951 319627 23126 296501 365615667 281174200 84394549 46918 17185944 14086166 41155383 34432421 1149750 0 44670511 53184873 3747462 3719669 2460962 2759621 201373786 92037266 111350591 109336520 156877068 196146678 15962218 5000000 13528728 12287624 7508089 10031295 415596706 440984867 49455575 55250019 866 230664 104128328 102442178 153584769 157922861 X 260154225 280810445 972123 1365972 885589 885589 262011937 283062006 415596706 440984867 X 27048665 -3779896 -2218702 X 0 1 X 1 1 1 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 154583 0 1 48762 203345 0 EXPLANATION OF LOBBYING ACTIVITIES: PART II-B, LINE 1: LINE 1G: COMPENSATION PAID TO HIRED LOBBYISTS TO MONITOR AND REVIEW LEGISLATION AT THE LOCAL, STATE, AND FEDERAL LEVELS. LINE 1I: FRED HUTCHINSON CANCER RESEARCH CENTER GOVERNMENT AFFAIRS OFFICES WORK WITH LOCAL AND NATIONAL GOVERNMENTS FOR ISSUES FACING SEATTLE CANCER CARE ALLIANCE. AMOUNT EXPENDED = $5,511 LINE 1I: WASHINGTON STATE HOSPITAL ASSOCIATION REPRESENTS MEMBER INTERESTS ON THE LOCAL AND STATE LEVEL. THIS AMOUNT REFLECTS DUES ALLOCATED TO LEGISLATIVE EFFORTS = $27,251 LINE 1I: ASSOCIATION OF DEDICATED CANCER CENTERS REPRESENTS MEMBER INTERESTS AT THE NATIONAL LEVEL. AMOUNT EXPENDED = $16,000 892849 36992 20455 3208 906178 900365 7260 14776 892849 800371 112671 12677 900365 757066 43305 800371 885589 -128523 757066 0.02270 0.97730 0.00000 1 0 2217938 2217938 120153517 43081787 77071730 3096432 1106209 1990223 55633599 38529825 17103774 20272300 9319445 10952855 109336520 X 384475000 -3779896 12815220 9035324 375439676 17224656 17224656 392664332 363819000 520351 520351 363298649 556517 1760499 2317016 365615665 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: INCOME FROM PERMANENTLY RESTRICTED ENDOWMENT FUNDS IS USED FOR THE PURPOSE OF PROVIDING UNCOMPENSATED PATIENT CARE. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: SCCA HAS OBTAINED A DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE INDICATING THAT IT IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, EXCEPT FOR UNRELATED BUSINESS INCOME TAX. SCCA RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. RECOGNIZED INCOME TAX POSITIONS ARE MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED. CHANGES IN RECOGNITION OR MEASUREMENT ARE REFLECTED IN THE PERIOD IN WHICH THE CHANGE IN JUDGMENT OCCURS. PART XI, LINE 2D - OTHER ADJUSTMENTS: BAD DEBT EXPENSE -1,756,724. CHANGE IN VALUE OF INVESTMENTS - PROCURE SEATTLE HOLDINGS, LLC 13,537,782. IMPAIRMENT GAIN 40,470. RESTRICTED REVENUES RELEASED 1,466,003. INVESTMENT EXPENSES -556,517. NET ASSETS RELEASED FROM RESTRICTIONS 85,000. ROUNDING -794. PART XI, LINE 4B - OTHER ADJUSTMENTS: GAIN/LOSS ON DISPOSAL OF FIXED ASSETS -95,656. COST OF GOODS SOLD REPORTED ON PART VIII -422,891. RESTRICTED REVENUES RELEASED 1,936,734. PROCURE SEATTLE HOLDINGS, LLC IMPAIRMENT 15,791,944. DIRECT SPECIAL EVENT EXPENSES -1,804. OTHER REVENUES RECORDED WITH EXPENSES ON FINANCIAL STATEMENTS 3,000. UNREALIZED GAIN/LOSS ON TEMPORARILY RESTRICTED ASSETS 13,329. PART XII, LINE 2D - OTHER ADJUSTMENTS: GAIN/LOSS ON DISPOSAL OF FIXED ASSETS 95,656. COST OF GOODS SOLD REPORTED ON PART VIII 422,891. DIRECT SPECIAL EVENT EXPENSES 1,804. PART XII, LINE 4B - OTHER ADJUSTMENTS: BAD DEBT EXPENSE 1,756,724. OTHER REVENUES RECORDED WITH EXPENSES ON FINANCIAL STATEMENTS 3,000. ROUNDING 775. EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 1500 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 324195 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 113900 NORTH AMERICA 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 1861 NORTH AMERICA 0 0 PROGRAM SERVICE TECHNOLOGY SUPPLIES 107962 NORTH AMERICA 0 0 FUNDRAISING N/A 1500 SOUTH AMERICA 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 870 RUSSIA & THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 191 0 0 0 0 0 0 551979 0 551979 0 0 0 0 0 0 SCCA SOURCES PERIPHERAL BLOOD STEM CELLS, BONE MARROW, AND CORD BLOOD FROM ALL OVER THE WORLD TO TREAT TRANSPLANT PATIENTS. IN DELIVERING STEM CELL TRANSPLANT SERVICES, SCCA SEEKS OUT THE MOST APPROPRIATE DONOR BASED ON CRITERIA OF HUMAN LEUKOCYTE ANTIGEN MATCH AND OTHER PERTINENT DONOR CRITERIA. HAVING THE CLOSEST POSSIBLE BONE MARROW DONOR MATCH IS CRUCIAL TO THE SURVIVAL OF THE PATIENT. ALSO, SOME OF THE FOREIGN DONOR ORGANIZATIONS HAVE HIGHER LEVELS OF TYPING ON THEIR DONOR WHICH REDUCED PATIENT COSTS. SCHEDULE F, PART I METHOD OF ACCOUNTING USED TO ACCOUNT FOR FOREIGN EXPENDITURES: ACCRUAL. X X X X X 1 UW ADVANCEMENT PO BOX 358045 SEATTLE WA 98195 FALL MAILING AND STRATEGY 0 78702 21646 57056 FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW DRIVE SEATTLE WA 98103 DEVELOPMENT, GIFT PROCESSING 0 0 21384 -21384 78702 43030 35672 AL AK AZ AR CO CT FL HI IL KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI CANCER WALK 21288 19484 1804 1804 21288 19484 1804 1804 1804 0 1 1 X 1 X 1 X 1 1 0 1 1 4197198 0 4197198 0.01150 32235562 15091367 17144195 0.04690 1416800 1331756 85044 0.00020 37849560 16423123 21426437 0.05860 4129147 1876218 2252929 0.00620 4044286 43755 4000531 0.01090 432883 0 432883 0.00120 5206924 427616 4779308 0.01310 1663397 0 1663397 0.00450 15476637 2347589 13129048 0.03590 53326197 18770712 34555485 0.09450 1 1756724 72755170 80462099 -7706929 X 1 1 1 1 SEATTLE CANCER CARE ALLIANCE

1959 NE PACIFIC STREET SEATTLE WA 98195

X X ACUTE CARE HOSPITAL SEATTLE CANCER CARE ALLIANCE 1 1 X X X X X X X X X 12 1 0 1 X X X X X X X X X 0 0 1 1 200.000000000000 1 300.000000000000 1 X X X X X X X 1 1 X X 1 1 X X X X 0 X X X 0 0 5 SEATTLE CANCER CARE ALLIANCE HOUSE

207 PONTIUS AVENUE N SEATTLE WA 98109

TEMPORARY MEDICAL HOUSING FACILITY SCCA NW HSPTL RADIATION ONCOLOGY CLNC

1560 N 115TH ST - SUITE G-16B SEATTLE WA 981338498

HOSPITAL BASED OUTPATIENT CLINIC SEATTLE CANCER CARE ALLIANCE

825 EASTLAKE AVENUE E SEATTLE WA 98109

HOSPITAL BASED OUTPATIENT CLINIC HALVORSON CANCER CENTER

12040 NE 128TH STREET KIRKLAND WA 98034

HOSPITAL BASED OUTPATIENT CLINIC SCCA PROTON THERAPY A PROCURE CENTER

1570 N 115TH STREET SEATTLE WA 98133

HOSPITAL BASED OUTPATIENT CLINIC PART I, LINE 3C: IN ACCORDANCE WITH WAC 246-453-040 AND SUBJECT TO SCCA FINANCIAL RESOURCES, PATIENTS WILL BE ELIGIBLE TO BE CONSIDERED FOR CHARITY CARE IF THEY SUBMIT THE NECESSARY APPLICATION AND IF THE PARTY RESPONSIBLE FOR PAYMENT HAS A FAMILY INCOME AT OR BELOW 300% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE. IF THE PARTY RESPONSIBLE FOR PAYMENT HAS A FAMILY INCOME AT OR BELOW 200% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE, THE PATIENT WILL BE ELIGIBLE FOR CHARITY CARE IN THE AMOUNT EQUAL TO THE UNPAID BALANCE REMAINING AFTER ALL SOURCES OF THIRD PARTY COVERAGE AND SPONSORSHIP HAVE BEEN EXHAUSTED. IF THE PARTY RESPONSIBLE FOR PAYMENT HAS A FAMILY INCOME BETWEEN 200% AND 300% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE, THE PATIENT WILL BE ELIGIBLE FOR CHARITY CARE BASED ON A SLIDING FEE SCALE FOR THE UNPAID BALANCE REMAINING AFTER ALL SOURCES OF THIRD PARTY COVERAGE AND SPONSORSHIP HAVE BEEN EXHAUSTED. RESPONSIBLE PARTIES WHOSE INCOME EXCEEDS 300% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE BUT WHO HAVE INCURRED CATASTROPHIC ACCOUNT BALANCES AFTER ALL SOURCES OF THIRD PARTY COVERAGE AND SPONSORSHIP WILL BE CONSIDERED FOR CHARITY CARE ON A CASE-BY-CASE BASIS. PART I, LINE 6A: SCCA COMPLETED AN ANNUAL REPORT FOR FY13 AND IT INCLUDES THE COMMUNITY BENEFIT REPORT INFORMATION. IT IS MADE AVAILABLE TO THE PUBLIC AT THE FRONT DESK AND ON OUR WEBSITE. SCCA'S COMMUNITY BENEFIT INFORMATION IS NOT DISCLOSED IN A REPORT PREPARED BY A RELATED ORGANIZATION. PART I, LINE 7: SCCA UTILIZED WORKSHEET 2 TO ARRIVE AT A COST TO CHARGE RATIO FOR COMPLETING LINE 7. PART I, LINE 7G: THERE ARE NO PHYSICIAN CLINIC EXPENSES INCLUDED. SCCA IS REPORTING NUTRITIONAL THERAPY SERVICES AS A SUBSIDIZED HEALTH SERVICE AS A COMMUNITY BENEFIT.SCCA PROVIDES AMBULATORY ONCOLOGY MEDICAL NUTRITION THERAPY SERVICES FOR ALL PATIENTS. SCCA EMPLOYS HIGHLY TRAINED, ONCOLOGY-CERTIFIED DIETITIANS TO TREAT PATIENTS THROUGHOUT THE CANCER SPECTRUM OF PREVENTION, ACTIVE TREATMENT, SURVIVORSHIP, AND PALLIATIVE CARE. THE NUTRITION SERVICES PROVIDED ARE NO LONGER COVERED BY INSURANCE OR MEDICARE. SCCA CONTINUES TO PROVIDE NUTRITION THERAPY SERVICES BECAUSE THIS IMPORTANT ASPECT OF CARE WOULD NOT BE AVAILABLE IN THE GENERAL COMMUNITY. PATIENTS UNDERGOING TRANSPLANTATION AND CANCER TREATMENTS SUFFER HIGH NUTRITION ACUITY REQUIRING SPECIALIZED KNOWLEDGE FOR EVALUATION AND TREATMENT. PART I, L7 COL(F): BAD DEBT EXPENSE INCLUDED IN FORM 990, PART IX IS $1,756,724. IT WAS SUBTRACTED UTILIZING WORKSHEET 1 FROM THE TOTAL ON FORM 990, PART IX TO ARRIVE AT THE DENOMINATOR USED TO CALCULATE THIS COLUMN. PART III, LINE 4: FOR PATIENTS WHO DO NOT QUALIFY FOR CHARITY CARE, SCCA RECOGNIZES REVENUE ON THE BASIS OF ITS STANDARD RATES FOR SERVICES PROVIDED (OR ON THE BASIS OF DISCOUNTED RATES, IF NEGOTIATED OR PROVIDED BY POLICY). ON THE BASIS OF HISTORICAL EXPERIENCE, A SIGNIFICANT PORTION OF SCCA'S PATIENTS WILL BE UNABLE OR UNWILLING TO PAY FOR THE SERVICES PROVIDED. THUS, SCCA RECORDS A SIGNIFICANT PROVISION FOR BAD DEBTS RELATED TO PATIENTS IN THE PERIOD THE SERVICES ARE PROVIDED. PART III, LINE 8: SCCA COMPLETED LINE 6 USING THE ALLOWABLE COSTS FROM THE AS-FILED MEDICARE COST REPORT FOR FY13. THE METHODOLOGY USED TO COMPLETE THE MEDICARE COST REPORT WAS BASED ON THE CMS PROVIDER REIMBURSEMENT MANUAL PUB 15.SCCA CONSIDERS THE SHORTFALL ON MEDICARE SERVICES TO BE 100% COMMUNITY BENEFIT. HAD SCCA NOT DELIVERED THE SERVICES, THE SERVICES AND FINANCIAL LOSS WOULD FALL TO ANOTHER COMMUNITY HOSPITAL. PART III, LINE 9B: PATIENTS WHO HAVE BEEN APPROVED FOR 100% CHARITY ARE REMOVED FROM THE COLLECTIONS WORKFLOW SO THEIR ACCOUNTS WILL NOT BE SENT TO COLLECTIONS. PATIENTS WHO HAVE BEEN AWARDED PARTIAL CHARITY (40% OR 60%) MAY BE SENT TO COLLECTIONS IF THE REMAINING PATIENT BALANCES ARE NOT PAID OR ARRANGEMENTS MADE WITHIN 91 DAYS OF THE FIRST BILLING CYCLE. PART III, SECTION A, LINE 2: THE EXPENSE REPORTED ON PART III, SECTION A, LINE 2 IS BAD DEBT EXPENSE AS REPORTED IN SCCA'S GAAP FINANCIAL STATEMENTS.DISCOUNTS ON ACCOUNTS PRIOR TO BAD DEBT STATUS: FOR A PATIENT WHO HAS INSURANCE, CONTRACTUAL ADJUSTMENTS ARE APPLIED TO THE ACCOUNT BASED ON THE INSURANCE COMPANY CONTRACT IN FORCE. THE REMAINING SELF PAY AMOUNTS ARE NOT FURTHER ADJUSTED. FOR A PATIENT WITH NO INSURANCE, A 10% DISCOUNT IS APPLIED AT TIME OF SERVICE. NO OTHER SPECIFIC DISCOUNTS ARE MADE TO PATIENT ACCOUNTS. AMOUNTS WRITTEN OFF TO BAD DEBT EXPENSE REPRESENT THE UNPAID BALANCE AFTER INSURANCE CONTRACTUAL ADJUSTMENT, OR SELF PAY DISCOUNT; AND ANY PAYMENTS RECEIVED. ONCE AN ACCOUNT IS IN BAD DEBT STATUS, ANY PAYMENTS RECEIVED ON A PATIENT ACCOUNT CONTINUE TO REDUCE THE OUTSTANDING PATIENT ACCOUNT LIABILITY.ESTIMATED AMOUNT FOR PATIENTS WHO WOULD QUALIFY FOR FINANCIAL ASSISTANCE:THE SCCA IDENTIFIES PATIENTS ELIGIBLE FOR FINANCIAL ASSISTANCE AND THE ACCOUNT IS DESIGNATED AS FINANCIAL ASSISTANCE WITH IN THE PATIENT ACCOUNTING SYSTEM. ALL OTHER ACCOUNTS ARE EVALUATED OVER A PERIOD OF TIME THROUGH A SERIES OF CRITERIA BEFORE DESIGNATION AS BAD DEBT. BECAUSE SCCA IS A SPECIALTY HOSPITAL TREATING CANCER PATIENTS, SCCA MAKES EVERY EFFORT IN COMMUNICATING WITH OUR PATIENTS THE PROGRAMS AND FINANCIAL ASSISTANCE POLICIES AVAILABLE TO ITS PATIENT POPULATION BEFORE, DURING, AND AFTER TREATMENT IS RECEIVED.COMMUNITY BENEFIT:SCCA BELIEVES THAT BAD DEBT EXPENSE SHOULD BE INCLUDIBLE IN THE CALCULATION OF THE COMMUNITY BENEFIT. SCCA PROVIDED TREATMENT TO THOSE PATIENTS UNABLE TO PAY THEIR BILL. IF SCCA DID NOT TREAT THESE PATIENTS, THEY WOULD BE TREATED BY SOMEONE ELSE IN THE COMMUNITY OR THROUGH A GOVERNMENTAL UNIT. SEATTLE CANCER CARE ALLIANCE PART V, SECTION B, LINE 3: SCCA CONDUCTED AN ONLINE SURVEY TO COLLECT INFORMATION ABOUT CANCER-RELATED HEALTH CONCERNS. THE SURVEY WAS SENT TO 58 INDIVIDUALS AND ORGANIZATIONS REPRESENTING HEALTHCARE PROVIDERS, COMMUNITY PARTNERS, CANCER SUPPORTIVE SERVICES, FOUNDATIONS, MEDIA, OTHER EDUCATIONAL PROVIDERS, COMMUNITY AND BUSINESS LEADERS, AND CANCER SURVIVORS FROM PREDOMINATELY KING, PIERCE, AND SNOHOMISH COUNTIES. IN ADDITION, SCCA IS PARTICIPATING IN A KING COUNTY-WIDE GROUP CALLED THE KING COUNTY COMMUNITY HEALTH NEEDS ASSESSMENT (KC CHNA) COLLABORATIVE. THIS GROUP REVIEWED SCCA'S COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) AND MADE SUGGESTIONS TO IMPROVE IT. THE COLLABORATION EFFORT IS LED BY THE SEATTLE KING COUNTY DEPARTMENT OF PUBLIC HEALTH AND INCLUDES MOST OF THE HOSPITALS IN KING COUNTY. THE PURPOSE OF THE KC CHNA COLLABORATIVE IS TO INSTITUTIONALIZE A COLLABORATIVE APPROACH TO CONDUCT A COMPREHENSIVE COMMUNITY HEALTH NEEDS ASSESSMENT FOR KING COUNTY AND TO IDENTIFY OPPORTUNITIES FOR THE DEVELOPMENT AND IMPLEMENTATION OF COLLECTIVE, DATA-DRIVEN, IMPLEMENTATION STRATEGIES OVER THE NEXT THREE YEARS. SEATTLE CANCER CARE ALLIANCE PART V, SECTION B, LINE 5C: SCCA DISTRIBUTED ITS CHNA AND SURVEY RESULTS TO ITS PATIENT AND FAMILY ADVISORY GROUP. THE SCCA PATIENT AND FAMILY ADVISORY GROUP IS MADE UP OF PAST AND PRESENT PATIENTS AND THEIR FAMILY MEMBERS. SCCA ALSO DISTRIBUTED ITS CHNA TO THE KING COUNTY CHNA COLLABORATION, WHICH IS A GROUP OF HOSPITALS FORMED TO WORK TOGETHER ON THE HEALTHIER HOSPITALS INITIATIVE. SEATTLE CANCER CARE ALLIANCE PART V, SECTION B, LINE 7: THE CHNA PROCESS IDENTIFIED THAT THE INCIDENCE RATE OF CANCER CONTINUES TO GROW AND CANCER IS A LEADING CAUSE OF DEATH IN KING, SNOHOMISH AND PIERCE COUNTIES. REDUCING THE INCIDENCE RATE OF CANCER IS THOUGHT TO OCCUR THROUGH NEW TECHNOLOGIES AND DRUG THERAPIES, BEHAVIOR MODIFICATION, AND EARLY DETECTION THROUGH SCREENING PROCESSES. BARRIERS TO ACCESS APPROPRIATE HEALTH SERVICES AND PREVENTION EFFORTS APPEAR TO BE UNDERUTILIZED IN THE VARIOUS SCCA COMMUNITIES. SCCA HAS IDENTIFIED OPPORTUNITIES FOR OUTREACH AND PREVENTATIVE EFFORTS TO ITS VARIOUS COMMUNITIES AS PART OF ITS CHNA GOALS. HOWEVER, BECAUSE OF CONSTRAINED RESOURCES, SCCA IS NOT CURRENTLY EXPLORING THE MOST EFFECTIVE WAYS TO REACH THE FOLLOWING COMMUNITIES: 1) YOUNG ADULTS (THOSE OF 18 YEARS AND YOUNGER), 2) LESBIAN, GAY, BISEXUAL, TRANSGENDER (LBGT) COMMUNITY, 3) HEALTH SCREENING FOR MALES. SEATTLE CANCER CARE ALLIANCE PART V, SECTION B, LINE 19D: SCCA DOES NOT OPERATE AN EMERGENCY ROOM FACILITY. SCCA HAS PROCEDURES IN PLACE WHEN A PATIENT ENTERS INTO AN EMERGENT CONDITION TO STABILIZE THE PATIENT AND MOVE THEM TO AN APPROPRIATE EMERGENCY FACILITY. SCCA STABILIZES THE PATIENT WITHOUT DISCRIMINATION AND ELIGIBILITY TO PAY. SEATTLE CANCER CARE ALLIANCE PART V, SECTION B, LINE 20D: TO DETERMINE THE MAXIMUM AMOUNT THAT CAN BE CHARGED TO FAP-ELIGIBLE INDIVIDUALS, SCCA USES THE REMAINING FAP PERCENTAGE MULTIPLIED BY THE GROSS CHARGES. IF THE PATIENT IS DEEMED FAP ELIGIBLE FOR 60%, THE AMOUNT BILLED TO THE ELIGIBLE PATIENT IS 40% MULTIPLIED BY THEIR GROSS BILLED CHARGES. PART V, SECTION B, LINE 6A SEATTLE CANCER CARE ALLIANCE'S IMPLEMENTATION POLICY IS INCLUDED IN ITS COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA). THE CHNA CAN BE FOUND AT THE FOLLOWING WEBSITE:HTTP://WWW.SEATTLECCA.ORG/SCCA-COMMUNITY-HEALTH-NEEDS-ASSESSMENT.CFM PART VI, LINE 2: SCCA IS A SPECIALTY HOSPITAL AND OUTPATIENT CLINIC DEDICATED TO PROVIDING STATE-OF-THE-ART PATIENT AND FAMILY CENTERED CARE, SUPPORTING THE CONDUCT OF CANCER CLINICAL RESEARCH AND EDUCATION, ENHANCING ACCESS TO IMPROVED CANCER INTERVENTIONS; AND ADVANCING THE STANDARD OF CANCER CARE, REGIONALLY AND BEYOND. IT BRINGS TOGETHER PHYSICIANS FROM THE FRED HUTCHINSON CANCER RESEARCH CENTER, SEATTLE CHILDREN'S, AND THE UNIVERSITY OF WASHINGTON IN A WORLD-CLASS TREATMENT CENTER. OUR NEEDS ASSESSMENT STRATEGY IS TO ANALYZE WHERE AND WHAT TYPE OF CANCER IS OCCURRING, DETERMINE WHERE COMPELLING SCIENCE EXISTS, AND MAKE INVESTMENTS TO GROW THESE PROGRAMS.IN CONJUNCTION WITH FRED HUTCHINSON CANCER RESEARCH CENTER, UNIVERSITY OF WASHINGTON, AND SEATTLE CHILDREN'S, SCCA REVIEWS THE OCCURRENCE RATES IN THE TYPES OF CANCERS IN COMPARISON TO WHERE RESEARCH DOES NOT EXIST AND MAKES STRATEGIC INVESTMENTS TO DEVELOP SCIENCE, BREAKTHROUGHS, AND TREATMENTS IN AREAS OF CANCER NOT BEING PURSUED BY OTHERS.WITH THE COMBINED EFFORTS OF ALL THREE INSTITUTIONS, STATE-OF-THE-ART RESEARCH IS CONDUCTED AND SHARED WITH THE COMMUNITY.SCCA COMPLETED A FORMAL COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) PROCESS THAT IS IN COMPLIANCE WITH THE PATIENT PROTECTION ACT AND IRS CODE SECTION 501(R). SCCA FOCUSED ON THE STATE OF WASHINGTON AND THE IMPACT OF CANCER, IDENTIFYING THE LEADING CAUSES OF DEATH FROM CANCER. SCCA DEFINED ITS CHNA COMMUNITY TO BE THE THREE SURROUNDING COUNTIES: KING, PIERCE, AND SNOHOMISH COUNTIES. A STUDY OF THE DEMOGRAPHICS OF THE THREE COUNTIES BY GENDER AND ETHNICITY AS COMPARED TO THE SCCA PATIENT POPULATION WAS ANALYZED. THE LEADING CAUSES OF DEATH IN THE THREE-COUNTY AREA VERSUS WASHINGTON STATE WERE REVIEWED. THE ANALYSIS IDENTIFIED CANCER AS THE LEADING CAUSE OF DEATH. FURTHER ANALYSIS WAS COMPLETED LOOKING AT THE TYPES OF CANCER CAUSING MORTALITY. THE NUMBER ONE CAUSE OF DEATH IN WASHINGTON STATE AND THE THREE SURROUNDING COUNTIES WAS IDENTIFIED TO BE LUNG CANCER, FOLLOWED BY PROSTATE, BREAST, COLORECTAL, AND PANCREAS CANCERS. AS PART OF THE CHNA PROCESS, SCCA LOOKED AT PREVENTION AND SCREENING AND THE CHRONIC DISEASE RISK FACTORS. SCCA REVIEWED ITS PROGRAMS ADDRESSING COMMUNITY NEED AND IDENTIFIED AREAS TO FOCUS ON TO HELP CLOSE THE GAP. SCCA IS IMPLEMENTING TARGETED OUTREACH AND EDUCATIONAL PROGRAMS TO PROVIDE RESOURCE INFORMATION, EDUCATION, AND PREVENTATIVE HEALTH MESSAGES THAT ARE CULTURALLY AND LINGUISTICALLY APPROPRIATE. PART VI, LINE 3: EACH PATIENT ENTERING INTO THE SCCA CLINIC IS GIVEN A BROCHURE DESCRIBING THE FINANCIAL PROGRAMS AVAILABLE WITH THE CONTACT INFORMATION. A FINANCIAL COORDINATOR IS AVAILABLE FREE OF CHARGE TO HELP PATIENTS SIFT THROUGH THE INFORMATION AND HELP COMPLETE THE NECESSARY PAPERWORK TO APPLY FOR ASSISTANCE. INTERPRETER SERVICES ARE AVAILABLE IF NEEDED TO HELP. PART VI, LINE 4: SCCA IS LOCATED IN SEATTLE, WA. THE PATIENT POPULATION UTILIZING THE SERVICES OF SCCA ARE PRIMARILY LOCATED IN THE PACIFIC NORTHWEST; HOWEVER, SCCA HAS PATIENTS FROM ALL OVER WORLD. SCCA IS COMMITTED TO PROVIDING STATE-OF-THE-ART, PATIENT AND FAMILY CENTERED CARE, SUPPORTING THE CONDUCT OF CANCER CLINICAL RESEARCH AND EDUCATION, ENHANCING ACCESS TO IMPROVED CANCER INTERVENTIONS, AND ADVANCING THE STANDARD OF CANCER CARE REGIONALLY AND NATIONALLY.THE REGIONAL POPULATION ESTIMATE FOR THE STATES COMPRISING THE PACIFIC NORTHWEST (WA, OR, ID, MT, AK) ACCORDING TO THE US CENSUS BUREAU FOR 2010 IS 13,822,842.THE SCCA NETWORK PROGRAM INCLUDES 10 COMMUNITY CANCER CENTER AFFILIATES IN WASHINGTON, ALASKA, AND MONTANA. THE AFFILIATIONS ARE WITH COMMUNITY CANCER CENTERS AND PROVIDE ACCESS TO RESOURCES AND THERAPIES FOR THEIR PATIENTS, WHICH INCLUDE THE MEDICALLY UNDERSERVED AREA (MUA) POPULATIONS. THE MUA PATIENT POPULATION RECEIVES THE BENEFIT OF SCCA'S EXPERTISE WITHOUT HAVING TO LEAVE HOME. THE LOCAL GEOGRAPHICAL AREA SCCA RESIDES IN CONSISTS OF KING, SNOHOMISH, AND PIERCE COUNTIES. THE METROPOLITAN AREA POPULATION ESTIMATE ACCORDING TO THE US CENSUS BUREAU FOR 2010 IS 3,439,809 FOR THREE COUNTIES. KING, SNOHOMISH, AND PIERCE COUNTIES ALL HAVE FEDERALLY-DESIGNATED MEDICALLY UNDERSERVED COMMUNITIES. AS OF 2011, KING COUNTY HAS SIX FEDERALLY QUALIFIED HEALTH CENTERS (FQHC) WITH FORTY-ONE OPERATING LOCATIONS. SNOHOMISH COUNTY HAS TWO FQHCS WITH SEVEN OPERATING LOCATIONS. PIERCE COUNTY HAS TWO FQHCS WITH THIRTEEN OPERATING LOCATIONS. PIERCE COUNTY IS CONSIDERED A MEDICALLY UNDERSERVED COUNTY BY THE WASHINGTON STATE DEPARTMENT OF PUBLIC HEALTH.SCCA HAS DIRECT RELATIONSHIPS WITH SEVERAL FEDERALLY QUALIFIED HEALTH CENTERS THAT ARE LOCATED IN A DESIGNATED MUA IN KING COUNTY, WASHINGTON. PUBLIC HEALTH SEATTLE KING COUNTY (PHSKC) AND SEA MAR HAVE SPECIFIC CONTRACTS WITH SCCA AS PART OF OUR OUTREACH SERVICES TO PROVIDE PREVENTIVE HEALTH SCREENINGS AND REACH THE LOCAL UNDERSERVED COMMUNITIES. THE SCCA'S RELATIONSHIP WITH PHSKC IS PART OF THE WASHINGTON BREAST AND CERVICAL HEALTH PROGRAM (WBCHP). THE PURPOSE OF WBCHP IS TO REDUCE MORTALITY AND MORBIDITY FROM BREAST AND CERVICAL CANCER BY EARLY DETECTION OF CANCER THROUGH REGULAR MAMMOGRAM AND PAP TEST SCREENINGS, DIAGNOSTIC SERVICES, AND PROMPT ACCESS TO CANCER TREATMENT. SCCA ACCEPTS REFERRALS FROM PHSKC WHEN THE PRIMARY CARE PHYSICIAN HAS DETECTED SOMETHING OF INTEREST. SCCA PERFORMS DIAGNOSTICS. IF THE PATIENTS ARE DEEMED TO HAVE CANCER, SCCA WILL TREAT THESE PATIENTS. SCCA ALSO HAS THE UNIQUE ABILITY TO HELP ENROLL PATIENTS INTO THE WBCHP PROGRAM. ONCE IDENTIFIED BY SCCA, THEY ARE FAST TRACKED AT THE WASHINGTON STATE DEPARTMENT OF SOCIAL AND HEALTH SERVICES INTO WBCHP. PATIENTS WHO COME TO SCCA DIRECTLY TO HAVE DIAGNOSTIC SERVICES COMPLETED AND CANCER IS FOUND CAN BE ENROLLED DIRECTLY BY THE SCCA INTO THE WBCHP. ENROLLMENT INTO WBCHP IS DEPENDENT ON ELIGIBILITY CRITERIA. WBCHP IS FUNDED BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION, WASHINGTON STATE, PUGET SOUND AFFILIATE SUSAN G. KOMEN BREAST CANCER FOUNDATION, AND THE BREAST CANCER PREVENTION FUND.SCCA HAS A SPECIAL RELATIONSHIP WITH SEA MAR. SEA MAR COMMUNITY HEALTH CENTER IS A COMMUNITY-BASED ORGANIZATION COMMITTED TO PROVIDING QUALITY, COMPREHENSIVE HEALTH, HUMAN, AND HOUSING SERVICES TO DIVERSE COMMUNITIES, SPECIALIZING IN SERVICE TO LATINOS. SEA MAR'S CLINICS ARE LOCATED IN TEN COUNTIES IN WASHINGTON STATE. THE SCCA'S RELATIONSHIP WITH SEA MAR IS TO PROVIDE CLINICAL EDUCATION OPPORTUNITIES FOR PRIMARY CARE PROVIDERS IN THE AREAS OF EARLY DETECTION AND PREVENTION OF CANCER. ANOTHER ASPECT OF THE SEA MAR RELATIONSHIP IS TO FOSTER CONTINUITY OF CARE FOR SEA MAR PATIENTS WHO ARE DIAGNOSED WITH CANCER BETWEEN SEA MAR, SCCA, AND SCCA'S NETWORK MEMBERS. PART VI, LINE 5: TODAY, CANCER PATIENTS HAVE MORE TREATMENT OPTIONS THAN EVER BEFORE. WE SEE THIS EVERY DAY AT SCCA, WHERE THERE'S A DRAMATIC INCREASE IN THE PACE OF INNOVATION. IN PART, THIS IS A "COMPOUNDING EFFECT" AS OUR LEGACY KNOWLEDGE OF THE HUMAN IMMUNE SYSTEM AND THE HUMAN GENOME BEGIN TO PAY GREATER, MORE BENEFICIAL DIVIDENDS. IT'S ALSO THE RESULT OF OUR RAPIDLY DEVELOPING ABILITY TO COMMAND VAST AMOUNTS OF DATA, WHICH NOW TRANSLATES RESEARCH INTO ACTIONABLE THERAPIES IN A MATTER OF MONTHS-RATHER THAN YEARS OR DECADES.IN THIS NEW ENVIRONMENT, IT NO LONGER MAKES SENSE TO TALK SEPARATELY ABOUT OUR CLINICAL BREAKTHROUGHS AND THE ORGANIZATIONAL EFFORTS WE ARE MAKING TO IMPROVE BOTH OUR EFFICIENCY AND THE EFFECTIVENESS OF TREATMENT PROTOCOLS. THERE ARE AMAZING INNOVATIONS TAKING PLACE IN BOTH AREAS, WHICH ARE BECOMING INCREASINGLY INTERTWINED. SCCA DOES WHAT IT CAN TO HELP PATIENTS IN NEED. NO ONE IS MORE SENSITIVE TO THE HIGH COST OF CANCER TREATMENT THAN WE ARE. AND WHEN PATIENTS COME TO US WHOSE INSURANCE (OR LACK THEREOF) DOESN'T COVER THE COST, WE ALWAYS TRY TO FIND A WAY. OVER THE LAST THREE YEARS, THE VALUE OF UNCOMPENSATED CARE WE'VE PROVIDED HAS TRIPLED. IN 2013 IT AMOUNTED TO MORE THAN $21 MILLION. LOOKING FORWARD, THERE IS NO DOUBT THAT WE AS AN ORGANIZATION- AS WELL AS OUR GOVERNMENT AND OUR CULTURE IN GENERAL-MUST DO A LOT OF HARD THINKING TO "RESTATE THE CANCER PROBLEM." STATISTICS ABOUT DEMOGRAPHIC TRENDS AND SPIRALING COST INCREASES ARE WELL KNOWN, BUT HERE'S A NUMBER THAT CAUGHT OUR ATTENTION: THE NUMBER OF PEOPLE DEVELOPING CANCER EACH YEAR IS EXPECTED TO INCREASE 45% BY 2030.CURRENTLY, OUR FUNDING SYSTEM IS IN CHAOS, WITH BUDGET CUTS IN FEDERAL PROGRAMS AND THE ENTIRE INSURANCE INDUSTRY TURNED UPSIDE DOWN AND INSIDE OUT. THESE CONDITIONS WILL NOT LAST FOREVER. THEY CANNOT. THE NEED IS TOO GREAT. FOR OUR PART, WE ARE COMPLETELY FOCUSED ON INNOVATING AND DELIVERING QUALITY CANCER TO PATIENTS. THAT SAID, A GROWING PERCENTAGE OF OUR RESOURCES WILL NECESSARILY BE DIRECTED TO SOLVING THE SYSTEMIC FUNDING CHALLENGES WE ALL NOW FACE. WE ARE INVENTIVE. WE WILL COME UP WITH SOLUTIONS. IN FACT, WE ARE ALREADY ATTACKING THE PROBLEM ON MULTIPLE FRONTS. HERE ARE SEVERAL EXAMPLES:PRECISION MEDICINE IS ONE OF OUR MOST IMPORTANT INITIATIVES FOR TREATING CANCER. IT'S ALSO AN EFFECTIVE TOOL FOR CONTROLLING COSTS. THANKS TO OUR DIAGNOSTIC TOOL, UW ONCOPLEX, WE ARE ABLE TO IDENTIFY SPECIFIC GENETIC SIGNATURES FOR MANY PATIENTS' DISEASES AND MATCH THEM WITH TARGETED THERAPIES KNOWN TO BE MOST EFFECTIVE. OUR INCREASING ABILITY TO AVOID INEFFECTIVE THERAPIES WILL SIGNIFICANTLY LOWER THE PHYSICAL, EMOTIONAL AND FINANCIAL COSTS OF CANCER TREATMENT. TRANSLATIONAL MEDICINE IS A RELATIVELY NEW SPECIALTY THAT FOCUSES ON IMPROVING THE CONNECTION BETWEEN LABORATORY SCIENCES AND ACTUAL PATIENT CARE IN THE CLINIC. IN 2013 WE RECRUITED A DYNAMIC TEAM-SOLID TUMOR TRANSLATIONAL RESEARCH (STTR)-LED BY ERIC HOLLAND, MD, PHD. STTR HARNESSES THE KNOWLEDGE OF EXPERTS IN MULTIPLE DISCIPLINES INCLUDING GENOMICS, BIOINFORMATICS, AND MATHEMATICAL MODELING TO SUPPLEMENT THE MORE TRADITIONAL APPROACHES TO ONCOLOGY. AS STTR'S DATA SET MATURES, WE EXPECT TO SEE VIABLE TREATMENTS MOVE FROM THE LABORATORY TO THE CLINIC AT A MUCH FASTER PACEHIGH-VALUE MEDICINE IS THE GOAL OF HICOR, THE HUTCHINSON INSTITUTE FOR CANCER OUTCOMES RESEARCH. HEADED BY SCOTT RAMSEY M.D., PH.D., HICOR ENTERS ITS SECOND YEAR WITH TWO MAJOR INITIATIVES: THE VALUE IN CANCER CARE INITIATIVE BRINGS TOGETHER PRACTITIONERS AND INSURERS ACROSS THE STATE OF WASHINGTON TO IDENTIFY CLINICALLY-ACTIONABLE METRICS THAT SIGNIFY HIGH VALUE. ON THE NATIONAL LEVEL, HICOR IS WORKING TO SOLVE A STUBBORN PROBLEM. THROUGH ITS CHOOSING WISELY PROGRAM, THE AMERICAN SOCIETY FOR CLINICAL ONCOLOGY (ASCO) HAS IDENTIFIED A NUMBER OF FREQUENTLY ORDERED AND COSTLY INTERVENTIONS THAT LACK EVIDENCE SUPPORTING THEIR USE OR VALUE IN CLINICAL CANCER CARE. BECAUSE MANY ONCOLOGISTS HAVE NOT CHANGED THEIR PRACTICES IN RESPONSE, HICOR IS NOW DEVELOPING A PROGRAM TO ADDRESS THIS GAP BETWEEN POLICY RECOMMENDATIONS AND IMPLEMENTATION.PREVENTIVE MEDICINE AND EARLY DETECTION HAVE LONG BEEN HELD FORWARD AS AN OBVIOUS WAY TO CUT THE COST OF TREATMENT. THIS IS INDISPUTABLE FOR COLON CANCER, FOR EXAMPLE. WE OFTEN REMARK THAT COLONOSCOPIES ARE SO EFFECTIVE IN DETECTING THIS CANCER THAT WE SHOULD NOT ONLY PAY FOR THE PROCEDURE, BUT ALSO TAKE PATIENTS TO AND FROM THE TREATMENT IN A LIMOUSINE, AND BUY THEM DINNER AFTERWARDS. THE SYSTEM WOULD STILL COME OUT AHEAD. STANDARDS FOR SOME OTHER CANCERS ARE NOT SO CLEAR-CUT, BUT THEY ARE EVOLVING. THIS YEAR WE ADOPTED NEW AGE- AND RISK-BASED GUIDELINES FOR SCREENING WOMEN AGAINST BREAST CANCER. AND WE ARE ACTING ON NEW RECOMMENDATIONS THAT SMOKERS BE SCREENED PROACTIVELY FOR LUNG CANCER WITH CT SCANS. THE SCCA NETWORK IS A CORE PART OF OUR MISSION. SINCE SCCA'S FOUNDING IN 1998 WE'VE COMMITTED OURSELVES TO HELPING OUR COMMUNITY BY EXTENDING ACCESS TO IMPROVED CANCER INTERVENTIONS AND ADVANCING THE STANDARD OF CARE BEYOND OUR SEATTLE CLINICS. CURRENTLY, WE HAVE NINE NETWORK MEMBER AFFILIATES AND ONE COMMUNITY PARTNER, WITH LOCATIONS ACROSS WASHINGTON STATE, AND ONE EACH IN MONTANA AND ALASKA.THE SCCA NETWORK NOT ONLY PROVIDES ACCESS TO THE SCCA FACULTY'S EXPERTISE IN CANCER CARE, BUT IT ALSO MAKES CLINICAL TRIALS AVAILABLE, MONITORS QUALITY STANDARDS, KEEPS DOCTORS ABREAST OF THE LATEST THINKING ON CLINICAL BEST PRACTICES, AND HOSTS A COMPREHENSIVE CANCER CONTINUED MEDICAL EDUCATION (CME) PROGRAM IN PARTNERSHIP WITH THE UNIVERSITY OF WASHINGTON MEDICAL EDUCATION OFFICE. THE ACCESS TO CLINICAL TRIALS, OF COURSE, IS AN IMPORTANT BENEFIT FOR PATIENTS WHO ARE NOT RESPONDING TO STANDARD TREATMENTS. DUE TO THE REGULATORY COMPLEXITY OF ADMINISTERING THESE TRIALS, THE NETWORK GOES TO GREAT LENGTHS TO ENSURE THAT SCCA'S PROCESS IS REPLICATED ACCURATELY. SCCA EVALUATES THE SITES BEFORE WE BRING THEM ON AS A MEMBER TO MAKE SURE THAT THEY HAVE THE CAPABILITY OF DOING RESEARCH. EACH AFFILIATE RECEIVES COMPREHENSIVE TRAINING IN THE FOLLOWING PROTOCOLS. BASED ON SCCA DOCTORS' RECOMMENDATIONS, AND EACH SITE'S SPECIFIC INTEREST, THE NETWORK THEN INITIATES ALL OF THE REGULATORY COMPLIANCE AND CONTRACTING PROCESSES TO ESTABLISH THE CLINICAL TRIAL FOR EACH SITE. CURRENTLY, THERE ARE APPROXIMATELY 30 TRIALS ALREADY IMPLEMENTED OR UNDER DEVELOPMENT ACROSS THE SCCA NETWORK. ADDITIONALLY, THE PROGRAM HAS ADOPTED THE NETWORK CLINICAL PERFORMANCE PROGRAM, WHICH IS, ESSENTIALLY, A SYSTEM FOR STANDARDIZED QUALITY MEASUREMENT. THEY ARE THE IDENTICAL STANDARDS THAT SCCA IS MEASURED AGAINST AND HELD ACCOUNTABLE FOR MEETING. EXCELLENT COMMUNICATION, ON AN ONGOING BASIS, IS THE BOND THAT KEEPS THE SCCA NETWORK RUNNING EFFICIENTLY. SCCA STAGES A STRATEGIC RETREAT EACH YEAR WITH EACH INDIVIDUAL AFFILIATE. THE FOCUS IS ALWAYS A SET OF SPECIFIC INITIATIVES THAT CAN RAISE THE LEVEL OF CARE IN ONCOLOGY THROUGHOUT THAT AFFILIATE'S COMMUNITY. IN ADDITION, THERE ARE THREE PHONE CONFERENCES EACH MONTH AND, WHEN AN AFFILIATE REQUESTS EDUCATIONAL UPDATES ON A SPECIFIC DISEASE OR A DIAGNOSTIC OR TREATMENT APPROACH, SCCA WILL PUT TOGETHER A MULTIDISCIPLINARY TEAM TO COME ON SITE TO ADDRESS THOSE ISSUES.CRITICALLY, AS GOVERNMENT SUPPORT IN THE FORM OF GRANTS AND REIMBURSEMENTS FOR CANCER CARE AND RESEARCH DECREASES, SCCA'S CHALLENGE, TO MEET PATIENTS' TREATMENT NEEDS AND CONTINUE OUR EXHILARATING PACE OF RESEARCH, IS TO FILL THESE GAPS. THE BEST WAY FORWARD, WE BELIEVE, IS TO WORK WITH OUR PARTNERS IN OUR COMMUNITY, REGION-AND GLOBALLY. SCCA'S VISION EMBRACES EDUCATING PEOPLE ABOUT PROVEN WAYS TO REDUCE THEIR RISK OF CANCER. WE'RE PROMOTING BETTER HEALTH IN THE COMMUNITY AT LARGE, INCLUDING SCCA'S MOBILE BREAST IMAGING MAMMOVAN CO-SPONSORED WITH SAFEWAY, AND THE SCCA SURVIVORSHIP PROGRAM.WE'RE ALSO WORKING WITH ENTREPRENEURIAL PHILANTHROPISTS TO SUPPORT CREATIVE EFFORTS TO RAISE FUNDING FOR OUR INITIATIVES. WE WELCOME VOLUNTEERS, PATIENT ADVOCATES, FAMILIES, AND EXTENDED COMMUNITIES TO WORK WITH US IN CONTINUING THE WORK OF ACCELERATING HOPE.SCCA REMAINS DEDICATED TO ADVANCING THE STANDARD OF CARE NOT ONLY WITHIN OUR CLINIC AND OUR NETWORK, BUT ALSO THROUGHOUT OUR REGION-AND FOR CANCER PATIENTS EVERYWHERE. PART VI, LINE 6: SCCA IS NOT PART OF AN AFFILIATED HEALTH CARE SYSTEM. PART VI, LINE 7: WASHINGTON STATE REQUIRES THE SCCA TO HAVE ITS CHNA INFORMATION AVAILABLE ON ITS WEBSITE 15 DAYS FOLLOWING THE FILING OF ITS 990 WITH THE IRS. ALSO, WA STATE HAS IMPLEMENTED COMPENSATION REPORTING REQUIREMENTS. SCCA HAS COMPLIED WITH THE COMPENSATION REPORTING REQUIREMENTS AND WILL COMPLY WITH THE ADDITIONAL REPORTING REQUIREMENTS FOR THE CHNA INFORMATION. 1 UNIVERSITY OF WASHINGTON FOUNDATION PO BOX 358045 SEATTLE WA 98195 943079432 501(C)(3) 560319 0 N/A N/A TO SUPPORT UNIVERSITY OF WASHINGTON FOUNDATION EVENTS. FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVE N SEATTLE WA 98109 237156071 501(C)(3) 320156 0 N/A N/A TO FUND RESEARCH SPECIFIC TO CANCER RESEARCH ACTIVITIES. UNIVERSITY OF WASHINGTON PHYSICIANS PO BOX 34115 SEATTLE WA 98124 911220843 501(C)(3) 37285 0 N/A N/A TO SUPPORT MAMMOVAN PROGRAM. BELLEVUE COLLEGE FOUNDATION 300 LANDERHOLM CIRCLE SE ROOM A101 BELLEVUE WA 98007 911051671 501(C)(3) 7500 0 N/A N/A TO SUPPORT RADIATION THERAPY PROGRAM. STARBUCKS CYCLING 8809 27TH AVENUE NW SEATTLE WA 98117 274072470 501(C)(3) 15000 0 N/A N/A TO SUPPORT RACING TEAMS WHILE ALSO SUPPORTING LOCAL COMMUNITIES. 5 0 CASH FOR EMERGENCIES (ONE TIME ASSISTANCE PROGRAM) 37 7653 0 N/A N/A FUNERAL/MEMORIAL SERVICES 1 200 0 N/A N/A TRANSPORTATION 123 6910 0 N/A N/A FOOD 814 64683 3420 FMV GIFT CARDS PROVIDED TO PATIENTS FOR FOOD AND GROCERY STORES. SHELTER 297 176288 100720 FMV RENTS PAID FOR PATIENTS. MEDICAL 10 7387 0 N/A N/A PARKING 29 6415 0 N/A N/A SUNDRIES 1076 0 22729 FMV BOOKS, BAGS, MAGAZINES, COMPACT DISCS, BLANKETS & OTHERS. UTILITIES 8 2401 0 N/A N/A WIGS 976 4108 27880 FMV HATS & WIGS FOR CANCER PATIENTS. PROSTHESIS 10 0 1583 FMV PARTS & SUPPLIES FOR PROSTHETICS. TICKETS 4772 0 195384 FMV EVENT TICKETS TO SPORTS GAMES, ART PERFORMANCES, AND LOCAL ATTRACTIONS. STEINBERG TUITION ASSISTANCE 3 4000 0 N/A N/A PEGGY MEANS SCHOLARSHIP 4 29474 0 N/A N/A PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: WITH REGARD TO GRANTS TO ORGANIZATIONS REPORTED ON SCHEDULE I, PART II, THE SCCA VERIFIES THE GRANTEES ARE QUALIFIED 501(C)(3) ORGANIZATIONS WITH A MISSION COMPATIBLE WITH THAT OF SCCA. THE SCCA RELIES ON THE GRANTEE ORGANIZATION MAINTAINING ITS TAX EXEMPT STATUS WITH THE IRS AND DOES NOT IMPOSE THE BURDEN OF REPORTING BACK TO SCCA AS TO THE EXPENDITURE OF GRANT FUNDS. WITH REGARD TO GRANTS OR OTHER ASSISTANCE TO INDIVIDUALS REPORTED ON SCHEDULE I, PART III, MOST OF THE REQUESTS FOR ASSISTANCE ARE MADE THROUGH PATIENT FAMILY SERVICES. THESE REQUESTS ARE CONSIDERED IN ACCORDANCE WITH A MODIFICATION TO SCCA'S CHARITY CARE POLICY AND ASSISTANCE IS PROVIDED IN RESPONSE TO SPECIFIC NEEDS OF INDIVIDUALS FOR THE INTENDED PURPOSE BY PAYING FOR CERTAIN ASSISTANCE DIRECTLY ON BEHALF OF THE INDIVIDUAL. ALSO, PATIENT FAMILY SERVICES MAINTAINS CONTACT WITH PATIENTS RECEIVING ASSISTANCE THROUGHOUT THEIR TREATMENT AT SCCA. WITH REGARD TO SCHOLARSHIPS GIVEN, AN APPLICATION IS MADE AND REVIEWED BY THE SENIOR MANAGEMENT STAFF. VERY SPECIFIC CRITERIA ARE REQUIRED. ONLY BONA FIDE TUITION AND FEES QUALIFY FOR FUNDING. X 1 1 X X X X 0 0 0 0 0 0 0 0 0 FRED APPELBAUM MD 307275 0 139167 0 0 0 0 0 0 0 446442 0 0 0 NORMAN HUBBARD 487074 0 63440 0 0 0 31995 0 15339 0 597848 0 0 0 MADELINE BUELT 323236 0 19176 0 0 0 31995 0 19934 0 394341 0 0 0 F MARC STEWART MD 224181 0 143167 0 0 0 0 0 0 0 367348 0 0 0 JONATHAN TINGSTAD 363186 0 36075 0 0 0 31995 0 20159 0 451415 0 0 0 DEBORAH GENTZEN 324626 0 32858 0 0 0 31995 0 19441 0 408920 0 0 0 DAVID ACKERSON 298693 0 30030 0 0 0 32261 0 9887 0 370871 0 0 0 CHERYL WYMAN 193635 0 13055 0 0 0 20223 0 15029 0 241942 0 0 0 GRETCHEN HANNA 196183 0 13000 0 0 0 20115 0 15020 0 244318 0 0 0 JOSEPH NORTON 192735 0 9750 0 0 0 19215 0 18708 0 240408 0 0 0 ZAKARIA RAMADAN-JRADI 186865 0 9953 0 0 0 18744 0 18615 0 234177 0 0 0 ALEANA WAITE 176502 0 11716 0 0 0 17585 0 14686 0 220489 0 0 0 KRISTINE LOGAN 158432 0 10043 0 0 0 14287 0 8853 0 191615 0 0 0 LINDA LAKE 157429 0 10123 0 0 0 14445 0 8867 0 190864 0 0 0 SUSAN HAMMOND 161921 0 10725 0 0 0 15631 0 14623 0 202900 0 0 0 MOREEN DUDLEY 144146 0 9708 0 0 0 13627 0 12638 0 180119 0 0 0 CAMILLE RAPACZ 142131 0 9546 0 0 0 13308 0 14331 0 179316 0 0 0 ALPHONSO EMERY 156249 0 7517 0 0 0 13123 0 8626 0 185515 0 0 0 MARGARET OWENS 165626 0 0 0 0 0 14156 0 1736 0 181518 0 0 0 BARBARA JAGELS 135149 0 9367 0 0 0 12955 0 18113 0 175584 0 0 0 MICHELLE HALL 133631 0 8950 0 0 0 12133 0 14234 0 168948 0 0 0 SHARI MCCLURE 132369 0 8620 0 0 0 11483 0 8242 0 160714 0 0 0 CLAIRE BECK KEELER 128682 0 8788 0 0 0 11801 0 18012 0 167283 0 0 0 PART I, LINE 1A SCCA LEADERSHIP TEAM HAS MEMBERSHIPS AT LOCAL CLUBS TO ENABLE MEETINGS AND RECRUITMENT TO TAKE PLACE. NORMAN HUBBARD, MARC STEWART, AND JONATHAN TINGSTAND RECEIVE THESE BENEFITS. SCCA HAS A DETAILED EXPENSE REIMBURSEMENT POLICY FOR TRAVEL AND ENTERTAINMENT. THE HEALTH/SOCIAL CLUB DUES ARE NOT SPECIFICALLY INCLUDED IN THE WRITTEN POLICY. SCCA REIMBURSES FOR THESE EXPENSES SUBJECT TO THE TERMS OF THE OVERALL POLICY. ANY PAYMENTS WHICH ARE A TAXABLE FRINGE BENEFIT ARE INCLUDED IN THE TAXABLE INCOME REPORTABLE ON FORM W-2 FOR THE RECIPIENT. ALL RELATED CORPORATE EXPENSES ARE MONITORED BY THE AP SUPERVISOR FOR PERSONAL/BUSINESS USE FOR COMPLIANCE WITH THE ACCOUNTABLE PLAN AND REIMBURSEMENT POLICY. SUPPLEMENTAL INFORMATION PART III FRED APPELBAUM, MD RECEIVED COMPENSATION OF $446,442 FROM FRED HUTCHINSON CANCER RESEARCH CENTER, AN UNRELATED ORGANIZATION FOR SERVICES PROVIDED TO SEATTLE CANCER CARE ALLIANCE. F. MARC STEWART, MD RECEIVED COMPENSATION OF $367,348 FROM FRED HUTCHINSON CANCER RESEARCH CENTER, AN UNRELATED ORGANIZATION FOR SERVICES PROVIDED TO SEATTLE CANCER CARE ALLIANCE. A WASHINGTON HEALTH CARE FACILITIES AUTHORITY 911108929 93978E2C5 2009-02-03 87819178 CAPITAL ACQUISITION, REFINANCE OLD DEBT ISSUED 3/6/2001 0 0 0 B WASHINGTON HEALTH CARE FACILITIES AUTHORITY 911108929 2010-11-18 21415000 TO REFUND 2008 WEEKLY RATE BONDS 0 0 0 A 5185000 87819178 7391894 1671200 35272376 43483521 2010 1 0 1 1 B 1172000 21415000 325000 21090000 2009 1 0 1 1 A 0 0 0 1 1 0.00550 0.00000 0.00550 0 0 1 B 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 1 0 0 0 0 0 0 1 B 0 1 0 0 1 0 0 0 1 A 1 B 1 PART III, LINE 4, COLUMN A THE PERCENTAGE REPORTED ON LINE 4 REPRESENTS THE PERCENTAGE OF RESEARCH REVENUE FROM BOTH GOVERNMENTAL AND INDUSTRY SPONSORED RESEARCH. GOVERNMENT SPONSORED RESEARCH FALLS INTO A PRIVATE BUSINESS USE SAFE HARBOR, INDUSTRY SPONSORED DOES NOT. BECAUSE THE COMBINED REVENUE FROM THE GOVERNMENT AND PRIVATELY SPONSORED RESEARCH IS LESS THAN THE APPLICABLE THRESHOLD, SCCA HAS ELECTED NOT TO DEVOTE THE RESOURCES REQUIRED TO ALLOCATE THE AGGREGATE RESEARCH REVENUE BETWEEN GOVERNMENT AND PRIVATELY SPONSORED RESEARCH. AS SUCH, PRIVATE BUSINESS USE DUE TO RESEARCH IS OVERSTATED. SCCA DOES NOT HAVE DIRECT CONTRACTS WITH INDUSTRY SPONSORED CORPORATIONS. SCCA PERFORMS SERVICES PRIMARILY FOR UNIVERSITY OF WASHINGTON, A GOVERNMENTAL ENTITY, AND FRED HUTCHINSON CANCER RESEARCH CENTER, A 501(C)(3) ENTITY. UNIVERSITY OF WASHINGTON AND FRED HUTCHINSON CANCER RESEARCH CENTER ARE CONDUCTING THE RESEARCH AND HAVE THE DIRECT CONTRACTS WITH THE GOVERNMENT AND PRIVATE INDUSTRY SPONSORED RESEARCH. PART IV, LINE 2A SCCA'S REBATE COMPUTATIONS FOR THE 2/3/2009 AND 11/10/2010 BOND ISSUES ARE NOT REQUIRED TO BE PERFORMED DURING THE 6/30/2013 TAX YEAR. MOREEN DUDLEY KEY EMPLOYEE 13950 PEGGY MEANS EMPLOYEE SCHOLARSHIP TUITION FOR MBA PROGRAM SEATTLE PROCURE MANAGEMENT LLC SEE BELOW. 766667 PAYMENT FOR SERVICES. RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: SHARED BOARD MEMBER AND OFFICERS. TWO SCCA OFFICERS AND ONE SCCA BOARD MEMBER ARE BOARD MEMBERS OF PROCURE SEATTLE HOLDINGS, LLC, WHICH IS THE 100% OWNER OF SEATTLE PROCURE MANAGEMENT, LLC. 0 X 4 56950 SELLING PRICE X 13831 SELLING PRICE X 185 3420 SELLING PRICE X 10 1583 SELLING PRICE X EVENT TICKETS 4772 195384 SELLING PRICE X HATS/WIGS 972 27880 SELLING PRICE X FURNITURE 2 323 SELLING PRICE X APPLIANCES 6 475 SELLING PRICE 0 0 1 0 METHOD FOR DETERMINING NUMBER OF CONTRIBUTIONS: PART I, COLUMN (B): THE NUMBER OF ITEMS RECEIVED WAS USED TO DETERMINE THE AMOUNTS IN COLUMN B. FORM 990, PART I, LINE 6: THE VOLUNTEERS OFFER DIRECT SUPPORT IN SOCIAL, EMOTIONAL, AND PRACTICAL WAYS TO CONNECT WITH PATIENTS AND FAMILIES THROUGHOUT EACH PHASE OF A PATIENT'S EXPERIENCE WITH SCCA. THE SCCA HAS 20 VOLUNTEER ROLES: BREAST CENTER, CHILD LIFE, DRIVERS, EVENTS COMMITTEE, HUTCH SCHOOL, RAIN OR SHINE, GUEST SERVICES, WIG FITTER, SCCA HOUSE KITCHEN HOST, SPECIAL EVENTS, PATIENT EDUCATION, SHINE, COSMETOLOGY/BARBER, WOMEN'S CENTER LOBBY, SCCA HOUSE CONCIERGE, PATIENT/FAMILY SERVICES, PHYSICAL THERAPY, COMFORT MASSAGE, HEALING MUSIC, GENERAL ONCOLOGY LOBBY. THE 18 MEMBERS OF THE BOARD ALSO SERVE AS VOLUNTEERS. NEW PROGRAM SERVICES FORM 990, PART III, LINE 2 SCCA HAS A MINORITY INTEREST IN A JOINT VENTURE, PROCURE SEATTLE HOLDINGS, LLC, A PROTON THERAPY CENTER WHICH OPENED IN 2013. FORM 990, PART VI, SECTION A, LINE 2 MARK GROUDINE, RICH MCCUNE, MYRA TANITA, AND FRED APPELBAUM HAVE BUSINESS RELATIONSHIPS. EACH NAMED INDIVIDUAL SERVES AS A SCCA BOARD MEMBER OR OFFICER, AND THESE INDIVIDUALS ARE ALSO CURRENT BOARD MEMBERS, OFFICERS, DIRECTORS, OR KEY EMPLOYEES OF ANOTHER ORGANIZATION. ROBB BAKEMEIER, LISA BRANDENBURG, MIKE DELMAN, AND BRUDER STAPLETON HAVE BUSINESS RELATIONSHIPS. EACH NAMED INDIVIDUAL SERVES AS A SCCA BOARD MEMBER, AND THESE INDIVIDUALS ARE ALSO BOARD MEMBERS, OFFICERS, DIRECTORS OR KEY EMPLOYEES OF ANOTHER ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 6 SCCA HAS THREE MEMBERS. MEMBERS MUST BE GOVERNMENTAL ENTITIES OR ORGANIZATIONS EXEMPT UNDER IRC SECTION 501(C)(3). EACH MEMBER CURRENTLY HAS A 33 1/3% VOTING INTEREST. NO NEW MEMBER MAY BE ADMITTED TO THE CORPORATION WITHOUT THE APPROVAL OF EXISTING MEMBERS HOLDING AGGREGATE VOTING INTERESTS OF AT LEAST 75%. FORM 990, PART VI, SECTION A, LINE 7A EACH MEMBER WILL APPOINT SIX MEMBERS OF THE EIGHTEEN DIRECTORS OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 7B THE BOARD OF DIRECTORS OF THE CORPORATION MAY NOT, EXCEPT BY AFFIRMATIVE VOTE OF 75% OF THE DIRECTORS IN OFFICE AND WITH THE APPROVAL OF THE MEMBERS HOLDING AGGREGATE VOTING INTERESTS OF AT LEAST 75%: (A) AMEND, ALTER OR REPEAL CERTAIN SECTIONS OF THE CORPORATION'S BYLAWS; (B) REMOVE ANY DIRECTOR OR THE CHAIR OF THE CORPORATION; PROVIDED THAT A MEMBER MAY REMOVE A DIRECTOR APPOINTED BY SUCH MEMBER AT ANY TIME; (C) AMEND THE ARTICLES OF INCORPORATION OF THE CORPORATION; (D) ADOPT A PLAN OF MERGER OR CONSOLIDATION WITH ANOTHER CORPORATION; (E) AUTHORIZE THE SALE, LEASE, OR EXCHANGE (OR PLEDGING AS SECURITY) OF ALL OR SUBSTANTIALLY ALL OF THE PROPERTY AND ASSETS OF THE CORPORATION OR ANY ASSET NOT IN THE ORDINARY COURSE OF BUSINESS; (F) AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE CORPORATION OR REVOKE PROCEEDINGS THEREFOR; (G) ADOPT A PLAN FOR THE DISTRIBUTION OF THE ASSETS OF THE CORPORATION; (H) AMEND, ALTER, OR REPEAL ANY RESOLUTION OF THE MEMBERS OF THE CORPORATION; (I) INITIATE OR RESOLVE LITIGATION IN WHICH THE CORPORATION IS A PARTY IF THE LITIGATION OR RESOLUTION WOULD HAVE A MATERIAL ADVERSE EFFECT ON THE FINANCIAL WELL-BEING OR PUBLIC PERCEPTION OF THE CORPORATION OR ITS MEMBERS; (J) CHANGE THE FUNDAMENTAL PURPOSES OF THE CORPORATION; (K) ENTER INTO ANY NEW LINE OF BUSINESS; (L) OR AUTHORIZE THE RELOCATION FROM THE UNIVERSITY OF WASHINGTON MEDICAL CENTER TO ANOTHER HOSPITAL FACILITY OF THE TWENTY INPATIENT BEDS FOR WHICH THE CORPORATION HAS BEEN GRANTED A HOSPITAL LICENSE. FINALLY, THE FOLLOWING IS SUBJECT TO APPROVAL BY THE CORPORATION'S MEMBERS: - THE CORPORATION'S ANNUAL BUDGET - APPOINTMENT OF THREE ADDITIONAL DIRECTORS TO THE BOARD EXECUTIVE COMMITTEE (IN ADDITION TO THE CORPORATION'S CHAIR, IMMEDIATE PAST CHAIR, VICE CHAIR, TREASURER, AND SECRETARY) - APPOINTMENT OF DIRECTORS TO THE BOARD GOVERNANCE COMMITTEE - APPOINTMENT OF TWO DIRECTORS TO THE BOARD FINANCE COMMITTEE (IN ADDITION TO THE TREASURER) - SELECTION OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS TO CONDUCT AN ANNUAL FINANCIAL AUDIT OF THE CORPORATION FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WAS PREPARED BY A PUBLIC ACCOUNTING FIRM AND INTERNALLY REVIEWED PRIOR TO PRESENTATION TO THE BOARD-APPOINTED FINANCE AND AUDIT COMMITTEE. THE FORM 990 WAS PROVIDED TO THE FINANCE AND AUDIT COMMITTEE FOR REVIEW BEFORE FILING. THE CHAIR OF THE FINANCE AND AUDIT COMMITTEE REPORTS TO THE FULL BOARD. ALL BOARD MEMBERS ARE PRESENTED WITH A COPY BEFORE FILING FORM 990. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS ANNUALLY MONITORED THROUGH A QUESTIONNAIRE. IT IS A POLICY OF THE SCCA FOR SELF REPORTING. THIS SELF REPORTING IS APPLICABLE TO THE BOARD OF DIRECTORS AND ALL MANAGEMENT STAFF. THE DETERMINATION OF WHETHER AN ISSUE EXISTS IS MADE BY THE INTEGRITY OFFICER. THE ESCALATION PROCESS IS TO THE SENIOR MANAGEMENT TEAM, AND, IF DEEMED APPROPRIATE, TO THE BOARD OF DIRECTORS INTEGRITY COMMITTEE, BOARD OF DIRECTORS GOVERNANCE COMMITTEE, AND LEGAL COUNSEL. CONFLICTS OF INTEREST ARE ADDRESSED IF AND WHEN THEY ARISE. THE CONFLICTED BOARD MEMBER RECUSES HIM OR HERSELF FROM DISCUSSION AND VOTING ON THE MATTER. FORM 990, PART VI, SECTION B, LINE 15 AN INDEPENDENT COMPENSATION CONSULTING FIRM PERFORMS A MARKET ANALYSIS OF EXECUTIVE PAY AT COMPARABLE ORGANIZATIONS. A CONSULTANT FROM THIS FIRM PRESENTS ITS FINDINGS TO THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVERY TWO YEARS. THE ANALYSIS WAS LAST PERFORMED AND PRESENTED IN MAY OF 2011. DUE TO A CHANGE IN THE PERFORMANCE REVIEW DATE, THE NEXT MARKET ANALYSIS WILL TAKE PLACE IN NOVEMBER 2013. IN THE INTERVENING YEARS, THE PRIOR YEAR'S MARKET ANALYSIS IS UPDATED USING AN APPROPRIATE INFLATION FACTOR FOR USE BY THE COMPENSATION COMMITTEE IN ITS ANNUAL REVIEW OF TOTAL COMPENSATION FOR THE OFFICERS. THE COMPENSATION COMMITTEE DOCUMENTS ITS MEETINGS AND DECISIONS IN A TIMELY MANNER. THE COMPENSATION COMMITTEE PROMPTLY REPORTS TO THE BOARD ALL ACTIONS TAKEN AND SIGNIFICANT ISSUES DISCUSSED AT ITS MEETINGS. FORM 990, PART VI, SECTION C, LINE 19 THE SCCA DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC. AS REQUIRED BY THE IRS, THE SCCA'S AUDITED FINANCIAL STATEMENTS ARE ATTACHED TO FORM 990, WHICH IS A PUBLIC DISCLOSURE DOCUMENT. OTHER FEES FORM 990, PART IX, LINE 11G AISA INPATIENT SERVICES: PROGRAM SERVICE EXPENSES 39,368,268. MANAGEMENT AND GENERAL EXPENSES 776,917. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 40,145,185. INFO TECH & ADMIN SERVICES: PROGRAM SERVICE EXPENSES 860,690. MANAGEMENT AND GENERAL EXPENSES 1,376,751. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,237,441. LAB SERVICES: PROGRAM SERVICE EXPENSES 9,878,293. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 9,878,293. OTHER AGREEMENTS: PROGRAM SERVICE EXPENSES 559,321. MANAGEMENT AND GENERAL EXPENSES 75,000. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 634,321. CLINIC SERVICES: PROGRAM SERVICE EXPENSES 5,789,270. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,789,270. MEDICAL LEADERSHIP & FACULTY SUPPORT: PROGRAM SERVICE EXPENSES 13,944,980. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 13,944,980. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 9: PROCURE SEATTLE HOLDINGS LLC - CHANGE IN VALUE OF SWAP 2,445,000. PROCURE SEATTLE HOLDINGS LLC - IMPAIRMENT LOSS -4,699,162. IMPAIRMENT GAINS 40,470. CONTRIBUTED ASSETS -5,010. PROCURE SEATTLE HOLDINGS LLC 420 NORTH WALNUT STREET BLOOMINGTON IN 47404 270817057 PROTON BEAM THERAPY CENTER DE EXCLUDED 0 5 25815660 1 0 0 0.19000